Business · 25/06/2021
FDA Announces Draft Guidance for Cancer Clinical Trial Eligibility Criteria
The FDA is releasing a draft guidance to help sponsors of cancer clinical trials determine eligibility for patients with non-curative cancers who have not received available therapy, aiming to increase trial options for these patients.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →